Dacomitinib, an Irreversible Pan-ErbB Inhibitor Significantly Abrogates Growth in Head and Neck Cancer Models That Exhibit Low Response to Cetuximab
Ferdows Ather(University of California, Los Angeles), Steven Wong(University of California, Los Angeles)
Cited by 35
Related Papers
No related papers found
Powered by citation graph analysis